pravastatin has been researched along with Ischemic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassola, N; Clezar, CN; Flumignan, CD; Flumignan, RL; Nakano, LC; Trevisani, VF | 1 |
| Aoki, S; Hosomi, N; Kagimura, T; Kitagawa, K; Maruyama, H; Matsumoto, M; Minematsu, K; Nagai, Y; Nakagawa, Y; Nezu, T; Origasa, H; Uchiyama, S | 1 |
1 review(s) available for pravastatin and Ischemic Stroke
| Article | Year |
|---|---|
Pharmacological interventions for asymptomatic carotid stenosis.
Topics: Aspirin; Atherosclerosis; Atorvastatin; Carotid Stenosis; Chlorthalidone; Fluvastatin; Hemorrhage; Humans; Ischemic Stroke; Metoprolol; Pravastatin; Probucol; Rosuvastatin Calcium; Stroke; Warfarin | 2023 |
1 trial(s) available for pravastatin and Ischemic Stroke
| Article | Year |
|---|---|
Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study.
Topics: Aged; Brain; Brain Infarction; Cerebrovascular Circulation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Ischemic Stroke; Male; Outcome Assessment, Health Care; Pravastatin; Proportional Hazards Models; Recurrence; Secondary Prevention | 2020 |